[Lipid metabolism disorders and deafness of the inner ear. Therapeutic approaches: clinical testing of clofibrate (Lipavlon: I.C.I. Pharma laboratories)].
D002994:Clofibrate / Q000627:therapeutic use*; D003638:Deafness / Q000209:etiology*; D004341:Drug Evaluation; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications* / Q000188:drug therapy
D002994:Clofibrate
Dysmétabolisme lipidique et surdités d'oreille interne approches thérapeutiques: essai clinique de clofibrate (lipavlon: laboratoires I.C.I. Pharma).